Title:
COMPOUNDS USEFUL FOR TREATMENT OR PREVENTION OF MUSCULAR DYSTROPHY AND DERIVATIVES FOR TREATMENT, AMELIORATION OR PREVENTION OF MUSCULAR DYSTROPHY IN MEDICINAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/138935
Kind Code:
A1
Abstract:
The present invention relates to a novel compound and a medicinal use of the novel compound. In particular, the present invention relates to a novel compound useful for the treatment and/or prevention of muscular dystrophy, including Duchenne muscular atrophy, and a medicinal use of the novel compound.
Inventors:
RYU HYUNG-CHUL (KR)
KIM JAE-SUN (KR)
LIM JEE-WOONG (KR)
LEE JU-YOUNG (KR)
SONG WENLING (KR)
KIM TAE-GON (KR)
KIM JAE-SUN (KR)
LIM JEE-WOONG (KR)
LEE JU-YOUNG (KR)
SONG WENLING (KR)
KIM TAE-GON (KR)
Application Number:
PCT/KR2019/018434
Publication Date:
July 02, 2020
Filing Date:
December 24, 2019
Export Citation:
Assignee:
J2H BIOTECH INC (KR)
International Classes:
C07D271/06; A61K31/4245; A61P21/00
Domestic Patent References:
| WO2016198971A1 | 2016-12-15 |
Foreign References:
| US6992096B2 | 2006-01-31 | |||
| US20110195932A1 | 2011-08-11 |
Other References:
NAMGOONG, J. H.: "Clinical potential of ataluren in the treatment of Duchenne muscular dystrophy", DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE, pages 37 - 48, XP055724362
PAYNE, E. T.: "Nutritional therapy improves function and complements corticosteroid intervention in mdx mice", MUSCLE & NERVE, 2006, XP055020170
PAYNE, E. T.: "Nutritional therapy improves function and complements corticosteroid intervention in mdx mice", MUSCLE & NERVE, 2006, XP055020170
Attorney, Agent or Firm:
PHIL & ONZI INT'L PATENT & LAW FIRM (KR)
Download PDF: